177 related articles for article (PubMed ID: 26244871)
1. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
Lin X; Chen L; Yao Y; Zhao R; Cui X; Chen J; Hou K; Zhang M; Su F; Chen J; Song E
Oncotarget; 2015 Aug; 6(24):20485-99. PubMed ID: 26244871
[TBL] [Abstract][Full Text] [Related]
2. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
[TBL] [Abstract][Full Text] [Related]
3. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
[TBL] [Abstract][Full Text] [Related]
4. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
5. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.
Su S; Liu Q; Chen J; Chen J; Chen F; He C; Huang D; Wu W; Lin L; Huang W; Zhang J; Cui X; Zheng F; Li H; Yao H; Su F; Song E
Cancer Cell; 2014 May; 25(5):605-20. PubMed ID: 24823638
[TBL] [Abstract][Full Text] [Related]
6. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10.
Gong C; Qu S; Lv XB; Liu B; Tan W; Nie Y; Su F; Liu Q; Yao H; Song E
Nat Commun; 2014 Nov; 5():5406. PubMed ID: 25406648
[TBL] [Abstract][Full Text] [Related]
7. CCL18-dependent translocation of AMAP1 is critical for epithelial to mesenchymal transition in breast cancer.
Li H; Zhang D; Yu J; Liu H; Chen Z; Zhong H; Wan Y
J Cell Physiol; 2018 Apr; 233(4):3207-3217. PubMed ID: 28834540
[TBL] [Abstract][Full Text] [Related]
8. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.
Chen J; Yao Y; Gong C; Yu F; Su S; Chen J; Liu B; Deng H; Wang F; Lin L; Yao H; Su F; Anderson KS; Liu Q; Ewen ME; Yao X; Song E
Cancer Cell; 2011 Apr; 19(4):541-55. PubMed ID: 21481794
[TBL] [Abstract][Full Text] [Related]
9. Discovery of CCL18 antagonist blocking breast cancer metastasis.
Liu Y; Zheng H; Li Q; Li S; Lai H; Song E; Li D; Chen J
Clin Exp Metastasis; 2019 Jun; 36(3):243-255. PubMed ID: 31062206
[TBL] [Abstract][Full Text] [Related]
10. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
Schmidt-Wolf R; Zissel G
Anticancer Res; 2020 Jun; 40(6):3097-3108. PubMed ID: 32487604
[TBL] [Abstract][Full Text] [Related]
11. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
12. CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway.
Wang Q; Tang Y; Yu H; Yin Q; Li M; Shi L; Zhang W; Li D; Li L
Mol Carcinog; 2016 Nov; 55(11):1688-1699. PubMed ID: 26457987
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
[TBL] [Abstract][Full Text] [Related]
14. Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis.
Li HY; Cui XY; Wu W; Yu FY; Yao HR; Liu Q; Song EW; Chen JQ
J Cell Biochem; 2014 Mar; 115(3):596-603. PubMed ID: 24142406
[TBL] [Abstract][Full Text] [Related]
15. CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway.
Qin Y; Wang J; Zhu G; Li G; Tan H; Chen C; Pi L; She L; Chen X; Wei M; Li Z; Liu Z; Huang D; Liu Y; Zhang X
J Cell Mol Med; 2019 Apr; 23(4):2689-2701. PubMed ID: 30768878
[TBL] [Abstract][Full Text] [Related]
16. CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.
Shi L; Zhang B; Sun X; Zhang X; Lv S; Li H; Wang X; Zhao C; Zhang H; Xie X; Wang Y; Zhang P
Mol Carcinog; 2016 Dec; 55(12):2051-2062. PubMed ID: 26756176
[TBL] [Abstract][Full Text] [Related]
17. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
18. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
19. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.
Wang L; Wang YX; Zhang DZ; Fang XJ; Sun PS; Xue HC
Biomed Pharmacother; 2016 Mar; 78():301-307. PubMed ID: 26898455
[TBL] [Abstract][Full Text] [Related]
20. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
